Joshua Bernstock: Prehospital Stroke Triage Has Hit a Ceiling
Joshua Bernstock, Visiting Scientist at Massachusetts Institute of Technology, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Prehospital stroke triage has hit a ceiling — and biomarkers are the way through it.
Our new Neurology paper just went live: a systematic review and network meta-analysis of 58 studies, 58,000+ patients, and 33 prehospital stroke scales evaluating detection of large vessel occlusion (LVO).
The takeaway is uncomfortable but important:
Clinical exam–based scales alone are no longer enough.
Yes, some scales perform better than others depending on setting and thresholds.
But across the board, sensitivity and specificity plateau in the ~80–90% range, with wide variability, limited generalizability, and heavy dependence on who is doing the exam and where it’s performed.
Meanwhile, LVOs account for a minority of ischemic strokes — yet drive the vast majority of disability and mortality.
This is where biomarkers change the game.
Just as troponin transformed MI diagnosis, integrating blood-based markers (e.g., GFAP, D-dimer) with clinical assessment offers something physical exams alone cannot:
-Pathophysiologic specificity
-Objective, reproducible signal
-The ability to distinguish ischemic vs hemorrhagic stroke before hospital arrival
Multiple prospective datasets now show that combining biomarkers with simple clinical scales can dramatically improve LVO detection, enabling:
-Smarter bypass decisions
-Faster thrombectomy
-Fewer futile transfers
-Better outcomes — especially in resource-limited settings
The next frontier in stroke care is not a better scale — it’s better biology, deployed earlier.
If we are serious about equity, speed, and outcomes in stroke systems of care, prehospital biomarker-enabled triage needs to move from “promising” to “standard.””
Title: Evaluating Prehospital Stroke Scales for Large Vessel Occlusion: A Systematic Review and Network Meta-Analysis
Authors: Noah Lee Ahmad Nawabi, Esteban Rivera Rivera, Daniel de Wilde, John L. Kilgallon, David I. Nawabi, Varun M. Bhave, Patrick Emedom-Nnamdi, Ari Kappel, Shivani D. Rangwala, Rodolfo E. Alcedo Guardia, Juan Vicenty-Padilla, Saef Izzy, Nirav J. Patel, Rose Du, Adam A. Dmytriw, Toby Gropen, David S. Liebeskind, Edoardo Gaude, Alfred Pokmeng See, Mohammed Ali Aziz-Sultan, Joshua D. Bernstock
Read the Full Article on Neurology Journals
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026